2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Acute myocardial infarction and transient elevated anticardiolipin antibody in a young adult with possible familial hypercholesterolemia: a case report : Anticardiolipin antibody and myocardial infarction

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Familial hypercholesterolemia (FH) can lead to premature coronary heart disease. Anticardiolipin antibody may be a contributor for thrombosis. Here, we report an adult with possible FH suffered from premature myocardial infarction that may be triggered by transient increased anticardiolipin antibody.

          Case presentation

          A 29-year-old male had presented with a history of 2-h chest pain and numbness of left upper arm before 5 days. The electrocardiogram (ECG) had demonstrated inferior wall myocardial infarction (MI). Five days later he was admitted to our hospital and diagnosed as acute MI and possible FH (premature coronary heart disease, low density lipoprotein cholesterol of 5.90 mmol/L) with increased anticardiolipin antibody (up to 120 RU/ml). Other auto-antibodies including β2-glicoprotein antibodies IgM, IgA, IgG, lupus anticoagulant (LA), antinuclear antibodies, anti-myocardial antibody were normal. Coronary artery angiography (CAG) showed right coronary artery was total occlusion from the middle segment. Then he underwent percutaneous coronary intervention with a stent. Four days later, he was discharged with complete recovery. CAG showed intra-stent restenosis and anticardiolipin antibody level was normal and the patient had no any symptoms at 6-month follow-up.

          Conclusions

          Transient elevated anticardiolipin antibody may be a trigger or biomarker of cardiac thrombotic events in younger atherosclerotic patients.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: not found
          • Article: not found

          Antiphospholipid syndrome

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study.

            To assess risk factors for a first thrombotic event in confirmed antiphospholipid (aPL) antibody carriers and to evaluate the efficacy of prophylactic treatments. Inclusion criteria were age 18-65 years, no history of thrombosis and two consecutive positive aPL results. Demographic, laboratory and clinical parameters were collected at enrolment, once a year during the follow-up and at the time of the thrombotic event, whenever that occurred. 258 subjects were prospectively observed between October 2004 and October 2008. The mean ± SD follow-up was 35.0 ± 11.9 months (range 1-48). A first thrombotic event (9 venous, 4 arterial and 1 transient ischaemic attack) occurred in 14 subjects (5.4%, annual incidence rate 1.86%). Hypertension and lupus anticoagulant (LA) were significantly predictive of thrombosis (both at p<0.05) and thromboprophylaxis was significantly protective during high-risk periods (p<0.05) according to univariate analysis. Hypertension and LA were identified by multivariate logistic regression analysis as independent risk factors for thrombosis (HR 3.8, 95% CI 1.3 to 11.1, p<0.05, and HR 3.9, 95% CI 1.1 to 14, p<0.05, respectively). Hypertension and LA are independent risk factors for thrombosis in aPL carriers. Thromboprophylaxis in these subjects should probably be limited to high-risk situations.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Familial hypercholesterolaemia: A global call to arms.

                Bookmark

                Author and article information

                Contributors
                sxin2017@126.com
                aqianwang2@126.com
                cardiozhuhai@sina.com
                384011782@qq.com
                1947714830@qq.com
                13679491692@163.com
                sallyzhangmin@126.com
                huangyanden@163.com
                xingzhoulzu@163.com
                yunshancao@126.com
                Journal
                BMC Cardiovasc Disord
                BMC Cardiovasc Disord
                BMC Cardiovascular Disorders
                BioMed Central (London )
                1471-2261
                27 June 2019
                27 June 2019
                2019
                : 19
                : 156
                Affiliations
                [1 ]Department of Cardiology, Gansu Provincial Hospital, Lanzhou University, Lanzhou, 730000 People’s Republic of China
                [2 ]ISNI 0000 0004 1797 6990, GRID grid.418117.a, School of Clinical Medicine, Gansu University of Chinese Medicine, ; Lanzhou, 730000 People’s Republic of China
                [3 ]ISNI 0000 0004 1761 9803, GRID grid.412194.b, School of Clinical Medicine, Ningxia Medical University, ; Lanzhou, 730000 People’s Republic of China
                [4 ]Department of Pathology, Gansu Provincial Hospital, Lanzhou University, Lanzhou, 730000 People’s Republic of China
                [5 ]Department of Radiology, Gansu Provincial Hospital, Lanzhou University, Lanzhou, 730000 People’s Republic of China
                Author information
                http://orcid.org/0000-0001-8463-1093
                Article
                1135
                10.1186/s12872-019-1135-y
                6598355
                31248367
                813ea703-044a-4e7e-a14b-a22987f4001c
                © The Author(s). 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 17 October 2018
                : 12 June 2019
                Funding
                Funded by: National Natural Science Foundation of China (CN)
                Award ID: 81460072
                Award Recipient :
                Funded by: CAS “Light of West China” Program
                Categories
                Case Report
                Custom metadata
                © The Author(s) 2019

                Cardiovascular Medicine
                familial hypercholesterolemia,thrombosis,myocardial infarction,anticardiolipin antibody

                Comments

                Comment on this article